Document is current
Any future updates will be listed below
-
Authors
Kwaśna, Julia
Cubała, Wiesław Jerzy
Kwaśny, Aleksander
Wilkowska, Alina
-
Funding
Funding for this research was provided by:
Gdański Uniwersytet Medyczny (01- 10024 / 0006051 / 01 / 221 / 221 / 0 / 2024, 01- 10024 / 0006051 / 01 / 221 / 221 / 0 / 2024, 01- 10024 / 0006051 / 01 / 221 / 221 / 0 / 2024, 01- 10024 / 0006051 / 01 / 221 / 221 / 0 / 2024)
- License Information
-
More Information
Article History
Received: 21 June 2024
Revised: 5 August 2024
Accepted: 6 August 2024
First Online: 26 August 2024
Declarations
:
: Julia Kwaśna has no conflict of interest. Aleksander Kwaśny has received research support from Beckley, GH Research, MSD.Alina Wilkowska has received research support from Angelini, Biogen, Eli Lilly and Company, 284 Janssen- Cilag, Lundbeck, Polpharma, Sanofi and Valeant. Wiesław Jerzy Cubała has received grants from Acadia, Angelini, Celon, Cortexyme, GH Research, HMNC Brain Health, IntraCellular Therapies, Janssen, MSD, Novartis, Otsuka. He has albo received honoraria from Angelini, Celon, Janssen, Novartis, Sanofi. He is a member of advisory boards in Angelini, Celon (terminated), Douglas Pharmaceuticals, Janssen, MSD, Novartis, Sanofi.
